Gene · 23532
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas. | Cancer Med | 2026 | 41968569 | PubTator, text mining | PubMed |
| Landscape of T-cell engagers in solid tumors. | Oncologist | 2026 | 41964902 | PubTator, text mining | PubMed |
| Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis. | Am J Dermatopathol | 2026 | 41945925 | PubTator, text mining | PubMed |
| PRAME-Positive Eruptive Melanocytic Nevi in the Setting of BRAF-Inhibitors. | J Cutan Pathol | 2026 | 41937281 | PubTator, text mining | PubMed |
| Clustering single-cell multi-omics data via weighted distance penalty and adaptive consistent graph regularization. | PLoS Comput Biol | 2026 | 41931510 | PubTator, text mining | PubMed |
| Identification of circRNA/lncRNA-miRNA-Transcription Factor-mRNA Networks to Identify Potential Biomarkers in Response to Neoadjuvant Therapy for Breast Cancer. | Breast Cancer (Dove Med Press) | 2026 | 41926491 | PubTator, text mining | PubMed |
| Spitz Melanocytoma With a Novel CPEB2::MAP3K2 Rearrangement: A Case Report. | J Cutan Pathol | 2026 | 41924997 | PubTator, text mining | PubMed |
| PRAME Immunohistochemical Expression as a Diagnostic Tool to Distinguish Between Endocervical and Endometrial Adenocarcinomas. | Int J Gynecol Pathol | 2026 | 41915930 | PubTator, text mining | PubMed |
| Clinicopathological Study of a Series of Melanomas With IDH1 Mutation. | Am J Dermatopathol | 2026 | 41894668 | PubTator, text mining | PubMed |
| Longitudinal Melanonychia in Children: Clinical and Histopathologic Features and Management with Literature Update. | Dermatopathology (Basel) | 2026 | 41892081 | PubTator, text mining | PubMed |
| PRAME Expression in Melanoacanthomas: Expanding the Spectrum of Positive Melanocytes in Sun-Exposed Skin. | Dermatopathology (Basel) | 2026 | 41892080 | PubTator, text mining | PubMed |
| Genital Disorders in Children: What Does a Biopsy Bring? | Dermatopathology (Basel) | 2026 | 41892079 | PubTator, text mining | PubMed |
| T-cell receptor-engineered T cells (TCR-e T cells): A novel cellular therapy for hematopoietic malignancies? | Transpl Immunol | 2026 | 41861971 | PubTator, text mining | PubMed |
| Emergence of the cancer antigen PRAME as key player in epigenetic dysregulation and renal tumorigenesis. | Cell Death Differ | 2026 | 41844897 | PubTator, text mining | PubMed |
| Revisiting the Immune Frontier in Soft Tissue Sarcomas. | Curr Oncol Rep | 2026 | 41843220 | PubTator, text mining | PubMed |
| Beyond the Stain: BAP1 -Inactivated Melanocytic Tumors With Retained BAP1 Nuclear Expression due to Missense Mutations in the Catalytic Domain. | J Cutan Pathol | 2026 | 41813058 | PubTator, text mining | PubMed |
| Primary melanoma of the gastrointestinal tract. | World J Gastroenterol | 2026 | 41809872 | PubTator, text mining | PubMed |
| Uveal Melanoma: Changing Paradigms of Treatment. | Ocul Oncol Pathol | 2026 | 41798271 | PubTator, text mining | PubMed |
| Small but mighty: Rhabdomyoblastic melanoma. | JAAD Case Rep | 2026 | 41798154 | PubTator, text mining | PubMed |
| Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas. | J Immunother Cancer | 2026 | 41791790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23532/papers?page=4